Article View: be.science
Article #410Cancer - Press Review (July 14, 2012) – Revue de presse (14 juillet 2012)
From: SMW
Date: Sat, 14 Jul 2012 15:29
Date: Sat, 14 Jul 2012 15:29
171 lines
8392 bytes
8392 bytes
Cancer – Press Review – Revue de Presse Every week on http://marclacroixcancerblog.blogspot.com Chaque semaine sur http://marclacroixcancerblog.blogspot.com Press Review (July 14, 2012) – Revue de presse (14 juillet 2012) A Life-Death Predictor Adds to a Cancer's Strain‎‎ Doctors try to give survival odds based on a tumor’s appearance and size, but often that is just an educated guess. By Gina Kolata. In The New York Times http://www.nytimes.com/2012/07/10/health/genetic-test-changes-game-in-cancer-prognosis.html?pagewanted=all Continued Progression in Cancer Diagnostics and Discussion “As our population ages, cancer will increase in incidence and in prevalence,” says Dr. Richard Schilsky. As I continue my interview with Dr. Schilsky, however, he appears to be promoting a more positive outlook on cancer. Now there is a new view on cancer, as it is coming to be seen more as a chronic illness rather than a life-ending prognosis. However, it is important to understand that cancer is not one disease.. By Jawad Arshad. In Triple Helix Online http://triplehelixblog.com/2012/07/continued-progression-in-cancer-diagnostics-and-discussion/ Metastatic breast cancer: Bevacizumab slows progression, but has no impact on survival‎ The cancer drug bevacizumab (Avastin®) offers only a modest benefit in delaying disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed the efficacy of bevacizumab in combination with chemotherapy, an established cancer treatment in this indication, and found no overall survival benefit when adding bevacizumab to chemotherapy. In Science Codex http://www.sciencecodex.com/metastatic_breast_cancer_bevacizumab_slows_progression_but_has_no_impact_on_survival-94770 Waiting for a Cancer Diagnosis‎‎‎‎ The period of time when you are waiting for a diagnosis is brutal. There's really no other way to describe it. As a nurse-turned-patient, I really had no idea just how difficult this waiting period really is. Waiting for my diagnosis of FBC (f-bomb breast cancer) was simultaneously heart-wrenching, nerve-wracking, confusing and downright scar‎. By Hollye Harrington Jacobs. In Huffington Post http://www.huffingtonpost.com/hollye-harrington-jacobs/cancer-diagnosis_b_1666186.html GSK pulls US bid to use Tykerb with Herceptin‎ British group GlaxoSmithKline has pulled a U.S. application seeking approval to use its breast cancer drug Tykerb in combination with Roche's rival product Herception for certain patients with advanced disease. In Reuters http://in.reuters.com/article/2012/07/12/glaxosmithkline-tykerb-idINL6E8IC9X620120712 Heavy people more likely to have colon polyps‎ Obese and overweight people are more likely to develop colon polyps, a possible precursor to cancer, than are slimmer individuals, according to a new review of past research. In Reuters http://www.reuters.com/article/2012/07/12/us-colon-polyp-idUSBRE86B18Q20120712 Cervical Cancer: The Silent Killer of Women in the Developing World‎ Like millions of mothers around the world, Adjaratou Kinda worries about her children's future. How will they fare in school? What career path will they choose? Will they be healthy and happy? But tragically, she must now also worry about how her five children will survive without their mother. Mrs. Kinda is one of more than 470,000 women diagnosed each year with cervical cancer, a prognosis that, in her West African home of Burkina Faso, is tantamount to a death sentence. By Liz Lange. In Huffington Post http://www.huffingtonpost.com/liz-lange/cervical-cancer-the-silent-killer-of-women-in-the-developing-world_b_1655231.html Vivre avec le cancer comme une maladie chronique‎ ‎‎ Le cancer n'est plus nécessairement synonyme de mort, selon la Fondation québécoise du cancer. Certaines personnes vivent avec plusieurs cancers sans jamais en décéder. Dans Canoë http://fr.canoe.ca/artdevivre/bienetre/article1/2012/07/10/19971416-qmi.html Cancer du sein : les femmes à grosse poitrine sont-elles plus à risques ? Existerait-il un lien entre la taille de la poitrine et le risque de développer un cancer du sein ? C’est ce que suggère une étude parue fin juin montrant que trois gènes impliqués dans les tumeurs mammaires sont retrouvés chez les femmes aux plus fortes poitrines. Des résultats à prendre avec des pincettes… Par Janlou Chaput. Dans Futura-Sciences http://www.futura-sciences.com/fr/news/t/medecine/d/cancer-du-sein-les-femmes-a-grosse-poitrine-sont-elles-plus-a-risques_39933/ Obésité, diabète, cancer : une partie de la solution dans nos assiettes ?‎ Bien manger pour se maintenir en bonne santé, mais pas seulement. Notre alimentation modifierait également l’expression des gènes et permettrait donc à nos enfants de bénéficier d'un meilleur "capital santé". Explications de Maximilien Rouer, président de BeCitizen, une société de conseil stratégique en développement durable. Par Maximilien Rouer. Dans Le Nouvel Observatuer http://leplus.nouvelobs.com/contribution/589629-obesite-diabete-cancer-une-partie-de-la-solution-dans-nos-assiettes.html Une mutation génétique rendrait certains traitements pour le cancer moins efficace Une équipe de 55 chercheurs, dirigée par le Dr. Sin Tiong ONG de l'Ecole de Médecine Duke-NUS (National University of Singapore) [1], a découvert une mutation génétique rendant les traitements de certains cancers moins efficaces. Ils ont également identifié une solution pour pallier à ce problème. Les conclusions de l'équipe ont été publiées dans la revue Nature Medicine. Dans bulletins-electroniques.com http://www.bulletins-electroniques.com/actualites/70513.htm Des Zurichois découvrent le point d’accès des métastases aux organes Des chercheurs de l’Université de Zurich ont découvert pour la première fois comment les métastases de cellules cancéreuses passent du sang dans les organes. Dans La Tribune de Genève http://www.tdg.ch/sante/sante/Des-Zurichois-decouvrent-le-point-d-acces-des-metastases-aux-organes-/story/12317148 Cancer Blog – Marc Lacroix – Le Blogue du Cancer http://marclacroixcancerblog.blogspot.com Marc Lacroix-Corman – InTextoResearch – Baelen (07/2012)
Technical Details
Message-ID:
<714a59d4-cee5-4763-ad9a-47de083a63b1@m8g2000yqo.googlegroups.com>Path:
arc1-ca.pugleaf.net!l9ni11715pbj.0!nntp.google.com!news1.google.com!postnews.google.com!m8g2000yqo.googlegroups.com!not-for-mailShow Full Headers
Complete Article Headers
X-Google-Thread: f5500,69df36e7bfb0c5b1,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Received: by 10.68.220.230 with SMTP id pz6mr4981230pbc.3.1342279741183;
Sat, 14 Jul 2012 08:29:01 -0700 (PDT)
Path: arc1-ca.pugleaf.net!l9ni11715pbj.0!nntp.google.com!news1.google.com!postnews.google.com!m8g2000yqo.googlegroups.com!not-for-mail
From: SMW <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press Review (July 14, 2012) – Revue de presse (14 juillet 2012)
Date: Sat, 14 Jul 2012 08:29:00 -0700 (PDT)
Organization: http://groups.google.com
Lines: 171
Message-ID: <714a59d4-cee5-4763-ad9a-47de083a63b1@m8g2000yqo.googlegroups.com>
NNTP-Posting-Host: 81.247.177.81
Mime-Version: 1.0
X-Trace: posting.google.com 1342279741 1423 127.0.0.1 (14 Jul 2012 15:29:01 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 14 Jul 2012 15:29:01 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: m8g2000yqo.googlegroups.com; posting-host=81.247.177.81; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-HTTP-UserAgent: Mozilla/5.0 (Windows NT 5.1) AppleWebKit/536.11 (KHTML, like
Gecko) Chrome/20.0.1132.57 Safari/536.11,gzip(gfe)
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable